Predictive Value of Tests
"Predictive Value of Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
| Descriptor ID |
D011237
|
| MeSH Number(s) |
E05.318.780.800.650 N05.715.360.780.700.640 N06.850.520.445.800.650
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Predictive Value of Tests".
Below are MeSH descriptors whose meaning is more specific than "Predictive Value of Tests".
This graph shows the total number of publications written about "Predictive Value of Tests" by people in this website by year, and whether "Predictive Value of Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 5 | 5 |
| 2003 | 0 | 12 | 12 |
| 2004 | 0 | 9 | 9 |
| 2005 | 0 | 10 | 10 |
| 2006 | 0 | 4 | 4 |
| 2007 | 0 | 12 | 12 |
| 2008 | 0 | 15 | 15 |
| 2009 | 1 | 22 | 23 |
| 2010 | 0 | 26 | 26 |
| 2011 | 0 | 15 | 15 |
| 2012 | 0 | 25 | 25 |
| 2013 | 0 | 23 | 23 |
| 2014 | 0 | 33 | 33 |
| 2015 | 0 | 31 | 31 |
| 2016 | 0 | 70 | 70 |
| 2017 | 5 | 874 | 879 |
| 2018 | 11 | 772 | 783 |
| 2019 | 2 | 326 | 328 |
| 2020 | 1 | 183 | 184 |
| 2021 | 0 | 128 | 128 |
To return to the timeline, click here.
Below are the most recent publications written about "Predictive Value of Tests" by people in Profiles.
-
In-hospital prognostic role of coronary atherosclerotic burden in COVID-19 patients. J Cardiovasc Med (Hagerstown). 2021 11 01; 22(11):818-827.
-
Predictors of mortality among long-term care residents with SARS-CoV-2 infection. J Am Geriatr Soc. 2021 12; 69(12):3377-3388.
-
MANAGEMENT OF ENDOCRINE DISEASE: Dysnatraemia in COVID-19: prevalence, prognostic impact, pathophysiology, and management. Eur J Endocrinol. 2021 Sep 06; 185(4):R103-R111.
-
Prevalence of abnormal cardiovascular magnetic resonance findings in recovered patients from COVID-19: a systematic review and meta-analysis. J Cardiovasc Magn Reson. 2021 09 03; 23(1):100.
-
Novel effects of acute COVID-19 on cardiac mechanical function: Two case studies. Physiol Rep. 2021 09; 9(17):e14998.
-
Differences in Cardiac Magnetic Resonance Imaging Markers Between Patients With COVID-19-associated Myocardial Injury and Patients With Clinically Suspected Myocarditis. J Thorac Imaging. 2021 Sep 01; 36(5):279-285.
-
Comparison of clinical and echocardiographic features of first and second waves of COVID-19 at a large, tertiary medical center serving a predominantly African American patient population. Int J Cardiovasc Imaging. 2021 Nov; 37(11):3181-3190.
-
Biochemical composition, transmission and diagnosis of SARS-CoV-2. Biosci Rep. 2021 08 27; 41(8).
-
The impact of COVID-19 on the sensitivity of D-dimer for pulmonary embolism. Acad Emerg Med. 2021 10; 28(10):1142-1149.
-
Efficacy of Unsupervised Self-Collected Mid-Turbinate FLOQSwabs for the Diagnosis of Coronavirus Disease 2019 (COVID-19). Viruses. 2021 08 22; 13(8).